These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22283636)

  • 1. Application of low dose of FK506 in pancreas transplantation model in Wistar-SD rats.
    Li F; Wang SX; Li QY; Yin HS
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):673-8. PubMed ID: 22283636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different dose of FK506 on endocrine function of pancreatic islets and damage of beta cells of pancreatic islets in a Wistar rat model.
    Li F; Li Q
    Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):333-8. PubMed ID: 20158440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrotoxicity of tacrolimus and preventive effect of diltiazem: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Lu YM; Liang JJ; Zhang J; Qiu J; Xie KJ; Hu JB; Zhong WD; Wang B; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):704-8. PubMed ID: 19595068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin a, but not FK506, induces osmotic lysis of pancreas zymogen granules, intra-acinar enzyme release, and lysosome instability by activating K+ channel.
    Lee WK; Braun M; Langelüddecke C; Thévenod F
    Pancreas; 2012 May; 41(4):596-604. PubMed ID: 22158076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
    Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin: a bone sparing immunosuppressant?
    Romero DF; Buchinsky FJ; Rucinski B; Cvetkovic M; Bryer HP; Liang XG; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial.
    Steinmüller TM; Gräf KJ; Schleicher J; Leder K; Bechstein WO; Mueller AR; Dette K; Schulz E; Neuhaus P
    Transplantation; 1994 Sep; 58(6):669-74. PubMed ID: 7524203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats.
    Cui Q; Hodgetts SI; Hu Y; Luo JM; Harvey AR
    Neuroscience; 2007 May; 146(3):986-99. PubMed ID: 17408862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats.
    Inoue T; Kawamura I; Matsuo M; Aketa M; Mabuchi M; Seki J; Goto T
    Transplantation; 2000 Sep; 70(5):774-9. PubMed ID: 11003356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
    Gao R; Lu Y; Xin YP; Zhang XH; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
    Abdelhadi M; Ericzon BG; Hultenby K; Sjöden G; Reinholt FP; Nordenström J
    Transpl Int; 2002 Apr; 15(4):180-7. PubMed ID: 11976740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
    Drachenberg CB; Klassen DK; Weir MR; Wiland A; Fink JC; Bartlett ST; Cangro CB; Blahut S; Papadimitriou JC
    Transplantation; 1999 Aug; 68(3):396-402. PubMed ID: 10459544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
    Gruessner RW; Fryer JP; Fasola C; Nakhleh RE; Gruessner AC; Kim S; Dunn DL; Pirenne J; Bekersky I; Benedetti E
    Transplantation; 1995 Jan; 59(2):164-71. PubMed ID: 7530871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine.
    Arai S; Teramoto S; Senoo Y
    J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response.
    Du S; Hiramatsu N; Hayakawa K; Kasai A; Okamura M; Huang T; Yao J; Takeda M; Araki I; Sawada N; Paton AW; Paton JC; Kitamura M
    J Immunol; 2009 Jun; 182(11):7201-11. PubMed ID: 19454717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
    Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.